This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Dimiter Dimitrov, PhD
Professor and Director, Center for Antibody Therapeutics at University of Pittsburgh Medical School


Dr. Dimitrov joined the National Cancer Institute in 1990 where he was tenured as Senior Investigator and appointed at the Senior Biomedical Research Service. He is currently Professor of Medicine and Director of the Center for Antibody Therapeutics at the University of Pittsburgh. His major long-term goal is the development of clinically useful therapeutics and vaccines based on human monoclonal antibodies in different formats including engineered antibody domains, chimeric antigen receptors, antibody drug conjugates, full size antibodies, bispecific antibodies and antibody-based fusion proteins. He has authored or co-authored more than 400 articles cited more than 22,000 times, several books and is inventor or coinventor of more than 100 inventions, patent applications or patents.

Agenda Sessions

  • Engineered Antibody Domains for Therapy of Cancer and AIDS